Medicare-funded breast cancer screenings jumped 44 percent from $666 million to $962 million from 2001 to 2009, yet those added costs did not improve early detection rates among the 65 and older Medicare population, according to a Yale School of Medicine study published recently in the Journal of the National Cancer Institute.
Connecticut’s share of funding from the National Cancer Institute has dropped 19 percent since 2010 – a steeper decline than many other states, an analysis of National Institutes of Health (NIH) data show.
Federal cancer institute funding to Connecticut fell to $33.4 million in 2014 – down from $41.1 million in 2010. The biggest grantee, Yale University, is receiving $7 million less from the National Cancer Institute (NCI), one of the NIH’s most prominent centers.
Dr. Erin Hofstatter, a young research scientist and breast cancer specialist at Yale’s Smilow Cancer Hospital, often prescribes tamoxifen, raloxifene and similar drugs to her patients. The drugs “reduce your risk (of cancer recurring) by half … but they come with baggage,” she tells her patients, “hot flashes, night sweats, leg cramps, small risk of uterine cancer, small risk of blood clots, small risk of stroke, you have to get your liver tested.”
Hofstatter’s unease with standard treatments for breast cancer has spurred her to seek alternative, safer ways to treat breast cancer. To this end, she has begun a study of black cohosh, in the pill form of an herb from the buttercup family, used for thousands of years by Native Americans to treat menopausal symptoms.
Ava Passley covered her nose and giggled as Dr. Jacob Hen walked into an examination room at his pediatric pulmonology office in Trumbull recently.
Ava, 3, of Bridgeport, knows what to expect from a visit with Hen, having dealt with asthma since she was 1. She also spent several nights in the hospital after an attack in 2012. "I had always heard about wheezing, but had never really heard it before that," her mother, Beverly Passley said. Continue Reading →
Thousands of Connecticut adults and children – some as young as 10 – struggle with eating disorders with many suffering secretly because the life-threatening psychiatric condition has gone undiagnosed and untreated, experts in the field report.
“We used to see eating disorders start at 13 or 14. Now we frequently see 10- and 11-year olds,” said Dr. Diane Mickley, founder and director of the Wilkins Center for Eating Disorders in Greenwich, which has treated females and males for three decades. Mickley is a founder and past president of the National Eating Disorders Association (NEDA).